Page last updated: 2024-10-16

choline and Dementia

choline has been researched along with Dementia in 88 studies

Dementia: An acquired organic mental disorder with loss of intellectual abilities of sufficient severity to interfere with social or occupational functioning. The dysfunction is multifaceted and involves memory, behavior, personality, judgment, attention, spatial relations, language, abstract thought, and other executive functions. The intellectual decline is usually progressive, and initially spares the level of consciousness.

Research Excerpts

ExcerptRelevanceReference
"We investigated the associations of dietary choline intake with the risk of incident dementia and with cognitive performance in middle-aged and older men in the prospective, population-based Kuopio Ischaemic Heart Disease Risk Factor Study."9.30Associations of dietary choline intake with risk of incident dementia and with cognitive performance: the Kuopio Ischaemic Heart Disease Risk Factor Study. ( Lönnroos, E; Salonen, JT; Tuomainen, TP; Virtanen, HEK; Virtanen, JK; Voutilainen, S; Ylilauri, MPT, 2019)
"The purpose of this study was to determine cerebral myo-inositol (mI) in adults with Down syndrome (DS), and to trace the chronobiology of DS to Alzheimer disease (AD)."7.69Role of increased cerebral myo-inositol in the dementia of Down syndrome. ( Ross, BD; Shonk, T, 1995)
"Deficits in certain long-axon cholinergic brain neurons have been demonstrated both in senile dementia of the Alzheimer type (SDAT) and, to a lesser degree, in association with the cognitive and memory impairments sometimes seen with normal aging."7.67Choline production from choline-containing phospholipids: a hypothetical role in Alzheimer's disease and aging. ( Maire, JC; Wurtman, RJ, 1984)
"Indices of presynaptic cholinergic nerve endings were assayed in neocortical biopsy samples from patients with presenile dementia."7.66Presynaptic cholinergic dysfunction in patients with dementia. ( Allen, SJ; Bowen, DM; Davison, AN; Neary, D; Sims, NR; Smith, CC; Thomas, DJ, 1983)
"The cholinergic system has been found to be crucially involved in cognitive function, with cholinergic dysfunction playing a pivotal role in the pathophysiology of dementia."6.53Cholinergic imaging in dementia spectrum disorders. ( Niccolini, F; Pagano, G; Politis, M; Roy, R, 2016)
"We investigated the associations of dietary choline intake with the risk of incident dementia and with cognitive performance in middle-aged and older men in the prospective, population-based Kuopio Ischaemic Heart Disease Risk Factor Study."5.30Associations of dietary choline intake with risk of incident dementia and with cognitive performance: the Kuopio Ischaemic Heart Disease Risk Factor Study. ( Lönnroos, E; Salonen, JT; Tuomainen, TP; Virtanen, HEK; Virtanen, JK; Voutilainen, S; Ylilauri, MPT, 2019)
"Mice with dementia were produced by mating sibling mice who had impaired memory for > 20 generations."5.29Administration of phosphatidylcholine increases brain acetylcholine concentration and improves memory in mice with dementia. ( Chung, SY; Hirata, R; Kokubu, T; Masuda, Y; Moriyama, T; Uezu, E; Uezu, K; Yamamoto, S; Yohena, N, 1995)
" Young males showed greater responsiveness to both drugs than young females, this being reflected in higher maxima of the dose-response curves obtained for the males."5.27The responsiveness of human eccrine sweat glands to choline and carbachol. Application to the study of peripheral cholinergic functioning in Alzheimer-type dementia. ( Bradshaw, CM; Lamb, K; Szabadi, E, 1983)
"Eight patients with Alzheimer's disease presenting whith memory difficulties and no significant intellectual deterioration were treated with 9 grams daily."5.26[Influence of choline on amnesia in Alzheimer's disease (author's transl)]. ( Agid, Y; Lhermitte, F; Signoret, JL; Whiteley, A, 1979)
"Plasmas of 12 patients currently taking part in a double-blind trial of lecithin in senile or presenile dementia of Alzheimer type were analysed for plasma choline levels at fixed intervals during lecithin treatment."5.05Fluctuations of free choline levels in plasma of Alzheimer patients receiving lecithin: preliminary observations. ( Chuaqui, P; Levy, R, 1982)
"We examined prospective associations of TMAO, γ-butyrobetaine, crotonobetaine, carnitine, choline, and betaine with risk of cognitive impairment and dementia among older adults aged 65 years and older in the Cardiovascular Health Study (CHS)."4.12Longitudinal Associations of Plasma TMAO and Related Metabolites with Cognitive Impairment and Dementia in Older Adults: The Cardiovascular Health Study. ( de Oliveira Otto, MC; Fretts, A; Hazen, SL; Lai, HTM; Lee, Y; Lemaitre, RN; Li, XS; Lopez, O; Mozaffarian, D; Nemet, I; Newman, AB; Siscovick, DS; Tang, WHW; Wang, M; Wang, Z, 2022)
" Although changes in myo-inositol and creatine occur in the early stages of AD, abnormalities of N-acetyl aspartate do not occur in mild AD but progressively change with dementia severity."3.71Brain metabolite concentration and dementia severity in Alzheimer's disease: a (1)H MRS study. ( Alexander, GE; Chang, L; Huang, W; Krasuski, JS; Rapoport, SI; Schapiro, MB; Shetty, HU, 2001)
"The purpose of this study was to determine cerebral myo-inositol (mI) in adults with Down syndrome (DS), and to trace the chronobiology of DS to Alzheimer disease (AD)."3.69Role of increased cerebral myo-inositol in the dementia of Down syndrome. ( Ross, BD; Shonk, T, 1995)
"Deficits in certain long-axon cholinergic brain neurons have been demonstrated both in senile dementia of the Alzheimer type (SDAT) and, to a lesser degree, in association with the cognitive and memory impairments sometimes seen with normal aging."3.67Choline production from choline-containing phospholipids: a hypothetical role in Alzheimer's disease and aging. ( Maire, JC; Wurtman, RJ, 1984)
"Indices of presynaptic cholinergic nerve endings were assayed in neocortical biopsy samples from patients with presenile dementia."3.66Presynaptic cholinergic dysfunction in patients with dementia. ( Allen, SJ; Bowen, DM; Davison, AN; Neary, D; Sims, NR; Smith, CC; Thomas, DJ, 1983)
"Recent studies have shown a defect in the cholinergic system of the cerebral cortex of patients suffering from nonvascular senile dementia."3.66Will drugs help patients with Alzheimer's disease? ( Kendall, MJ, 1979)
"Dementia was an independent predictor of metabolite values."2.73Magnetic resonance spectroscopy performance for detection of dementia, Alzheimer's disease and mild cognitive impairment in a community-based survey. ( Antúnez, C; Carles, R; Fortuna, L; García Santos, JM; Gavrila, D; Jiménez Veiga, J; Navarro, C; Parrilla, G; Salmerón, D; Tormo, MJ; Torres del Río, S, 2008)
"Choline is a critical nutrient for cognitive development, metabolism and liver function, and regulation of homocysteine metabolism."2.72[Importance of choline in cognitive function]. ( Aparicio, A; López-Sobaler, AM; Lorenzo Mora, AM; Ortega, RMª; Peral Suárez, Á; Salas González, MªD, 2021)
"The cholinergic system has been found to be crucially involved in cognitive function, with cholinergic dysfunction playing a pivotal role in the pathophysiology of dementia."2.53Cholinergic imaging in dementia spectrum disorders. ( Niccolini, F; Pagano, G; Politis, M; Roy, R, 2016)
"We validated the utility of SPM8 plus DARTEL (VSRAD) combined with magnetic resonance spectroscopy (1H MRS) as an adjunct screening technique for dementia due to Alzheimer's disease (AD)."1.40Utility of SPM8 plus DARTEL (VSRAD) combined with magnetic resonance spectroscopy as adjunct techniques for screening and predicting dementia due to Alzheimer's disease in clinical practice. ( Arai, H; Fujii, C; Hata, S; Higuchi, S; Igarashi, K; Ishii, R; Iwai, N; Moriya, M; Ohrui, T; Suzuki, T; Tokuda, T; Uemura, K; Waragai, M; Yoshida, M, 2014)
"Choline (Cho)/Cr was higher than normal in patients with AD, FTLD, and DLB."1.321H MR spectroscopy in common dementias. ( Boeve, BF; Edland, SD; Ferman, TJ; Ivnik, RJ; Jack, CR; Kantarci, K; Knopman, DS; O'Brien, PC; Petersen, RC; Smith, GE; Tang-Wai, DF; Tangalos, EG; Weigand, SD, 2004)
"Mice with dementia were produced by mating sibling mice who had impaired memory for > 20 generations."1.29Administration of phosphatidylcholine increases brain acetylcholine concentration and improves memory in mice with dementia. ( Chung, SY; Hirata, R; Kokubu, T; Masuda, Y; Moriyama, T; Uezu, E; Uezu, K; Yamamoto, S; Yohena, N, 1995)
" Young males showed greater responsiveness to both drugs than young females, this being reflected in higher maxima of the dose-response curves obtained for the males."1.27The responsiveness of human eccrine sweat glands to choline and carbachol. Application to the study of peripheral cholinergic functioning in Alzheimer-type dementia. ( Bradshaw, CM; Lamb, K; Szabadi, E, 1983)
"Eight patients with Alzheimer's disease presenting whith memory difficulties and no significant intellectual deterioration were treated with 9 grams daily."1.26[Influence of choline on amnesia in Alzheimer's disease (author's transl)]. ( Agid, Y; Lhermitte, F; Signoret, JL; Whiteley, A, 1979)

Research

Studies (88)

TimeframeStudies, this research(%)All Research%
pre-199055 (62.50)18.7374
1990's9 (10.23)18.2507
2000's12 (13.64)29.6817
2010's9 (10.23)24.3611
2020's3 (3.41)2.80

Authors

AuthorsStudies
de Oliveira Otto, MC1
Li, XS1
Wang, Z1
Siscovick, DS1
Newman, AB1
Lai, HTM1
Nemet, I1
Lee, Y1
Wang, M1
Fretts, A1
Lemaitre, RN1
Tang, WHW1
Lopez, O1
Hazen, SL1
Mozaffarian, D1
Shea, TB1
Hildre, AS1
Solvang, SH1
Aarsland, D1
Midtun, Ø1
McCann, A1
Ervik, AO1
Nygård, O1
Ueland, PM1
Nordrehaug, JE1
Giil, LM1
López-Sobaler, AM1
Lorenzo Mora, AM1
Salas González, MªD1
Peral Suárez, Á1
Aparicio, A1
Ortega, RMª1
Reddan, JM1
Macpherson, H1
White, DJ1
Scholey, A1
Pipingas, A1
Ylilauri, MPT1
Voutilainen, S1
Lönnroos, E1
Virtanen, HEK1
Tuomainen, TP1
Salonen, JT1
Virtanen, JK1
Herrmann, W1
Obeid, R1
Kantarci, K2
Targosz-Gajniak, MG1
Siuda, JS1
Wicher, MM1
Banasik, TJ1
Bujak, MA1
Augusciak-Duma, AM1
Opala, G1
Waragai, M1
Hata, S1
Suzuki, T1
Ishii, R1
Fujii, C1
Tokuda, T1
Arai, H1
Ohrui, T1
Higuchi, S1
Yoshida, M1
Igarashi, K1
Moriya, M1
Iwai, N1
Uemura, K1
Almuqbel, M1
Melzer, TR1
Myall, DJ1
MacAskill, MR1
Pitcher, TL1
Livingston, L1
Wood, KL1
Keenan, RJ1
Dalrymple-Alford, JC1
Anderson, TJ1
Roy, R1
Niccolini, F1
Pagano, G1
Politis, M1
García Santos, JM1
Gavrila, D1
Antúnez, C1
Tormo, MJ1
Salmerón, D1
Carles, R1
Jiménez Veiga, J1
Parrilla, G1
Torres del Río, S1
Fortuna, L1
Navarro, C1
Caserta, MT1
Ragin, A1
Hermida, AP1
Ahrens, RJ1
Wise, L1
Pilatus, U1
Lais, C1
Rochmont, Adu M1
Kratzsch, T1
Frölich, L1
Maurer, K1
Zanella, FE1
Lanfermann, H1
Pantel, J1
Weiss, U1
Bacher, R1
Vonbank, H1
Kemmler, G1
Lingg, A1
Marksteiner, J1
Kizu, O1
Yamada, K1
Ito, H1
Nishimura, T1
Petersen, RC1
Boeve, BF1
Knopman, DS1
Tang-Wai, DF1
O'Brien, PC1
Weigand, SD1
Edland, SD1
Smith, GE1
Ivnik, RJ1
Ferman, TJ1
Tangalos, EG1
Jack, CR1
Frederick, BD1
Lyoo, IK1
Satlin, A1
Ahn, KH1
Kim, MJ1
Yurgelun-Todd, DA1
Cohen, BM3
Renshaw, PF2
Pfefferbaum, A1
Adalsteinsson, E1
Sullivan, EV1
Metastasio, A1
Rinaldi, P1
Tarducci, R1
Mariani, E1
Feliziani, FT1
Cherubini, A1
Pelliccioli, GP1
Gobbi, G1
Senin, U1
Mecocci, P1
Rami, L1
Caprile, C1
Gómez-Ansón, B1
Sánchez-Valle, R1
Monte, GC1
Bosch, B1
Molinuevo, JL1
Xuan, X1
Ding, M1
Gong, X1
Jolles, J1
Verhoeven, WM1
Hier, DB1
Caplan, LR1
Carolei, A1
Di Piero, V1
Squitieri, G1
Murphy, MF1
Davis, KL3
McGeer, EG1
Fisman, M2
Pomara, N4
Stanley, M2
Flentge, F1
van den Berg, CJ1
Davies, P1
Kameyama, M1
Spar, JE1
Price, DL1
Whitehouse, PJ1
Struble, RG1
Coyle, JT1
Clark, AW1
Delong, MR1
Cork, LC1
Hedreen, JC1
Banay-Schwartz, M1
Block, R1
Gershon, S2
Maire, JC1
Wurtman, RJ2
Vatassery, GT1
Maletta, GJ1
Paggi, A1
Quattrini, A1
Ortenzi, A1
Cianci, F1
Silvestri, R1
Mancini, S1
Ball, MJ1
Marchbanks, RM2
Sims, NR1
Bowen, DM2
Allen, SJ1
Smith, CC1
Neary, D1
Thomas, DJ1
Davison, AN2
Lamb, K1
Bradshaw, CM1
Szabadi, E1
Stramba-Badiale, M1
Scillieri, E1
Domino, EF2
Yoon, H1
Brinkman, S1
Tamminga, CA1
Canter, NL1
Hallett, M1
Growdon, JH2
Merskey, H1
Helmes, E1
McCready, J1
Colhoun, EH1
Rylett, BJ1
Chuaqui, P1
Levy, R2
Barclay, LL1
Blass, JP1
Kopp, U2
Hanin, I3
Brinkman, SD1
Goodnick, PJ1
Barnett, N1
Hsieh, JY1
Levy, MI2
Horvath, TB2
Davis, BM2
Mohs, RC2
Etienne, P2
Dastoor, D2
Gauthier, S2
Ludwick, R1
Collier, B2
Friedman, E1
Sherman, KA1
Ferris, SH1
Reisberg, B1
Bartus, RT1
Schneck, MK1
Glen, AI1
Yates, CM1
Simpson, J1
Christie, JE1
Shering, A1
Whalley, LJ1
Jellinek, EH1
Kent, S1
Thal, LJ2
Rosen, W2
Sharpless, NS2
Crystal, H2
Richter, JA1
Perry, EK1
Tomlinson, BE1
Corkin, S1
Fovall, P1
Dysken, MW1
Lazarus, LW1
Davis, JM1
Kahn, RL1
Jope, R1
Finkel, S1
Rattan, P1
Tinklenberg, JR1
Rosenberg, GS1
Constans, JM1
Meyerhoff, DJ1
Gerson, J1
MacKay, S1
Norman, D1
Fein, G1
Weiner, MW1
Shonk, T1
Ross, BD1
Stoll, AL2
Yurgelun-Todd, D1
Babb, SM1
Chung, SY1
Moriyama, T1
Uezu, E1
Uezu, K1
Hirata, R1
Yohena, N1
Masuda, Y1
Kokubu, T1
Yamamoto, S1
Bowen, BC1
Block, RE1
Sanchez-Ramos, J1
Pattany, PM1
Lampman, DA1
Murdoch, JB1
Quencer, RM1
Egashira, T1
Kanfer, JN1
Pettegrew, JW1
Moossy, J1
McCartney, DG1
Huang, W1
Alexander, GE1
Chang, L1
Shetty, HU1
Krasuski, JS1
Rapoport, SI1
Schapiro, MB1
Boyd, WD1
Graham-White, J1
Blackwood, G1
Glen, I1
McQueen, J1
Spillane, JA1
Goodhart, MJ1
White, P1
Johnson, G1
Mendis, T1
Cole, M1
Muller, HF1
Smith, CM2
Swash, M2
Exton-Smith, AN1
Phillips, MJ1
Overstall, PW1
Piper, ME1
Bailey, MR1
Signoret, JL2
Whiteley, A2
Lhermitte, F2
Kolata, GB1
Renvoize, EB1
Jerram, T1
Kendall, MJ1
Agid, Y1
Aquilonius, SM1
Ceder, G1
Lying-Tunell, U1
Malmlund, HO1
Schuberth, J1
Serra, F1
Diaspri, GP1
Gasbarrini, A1
Giancane, S1
Rimondi, A1
Tamè, MR1
Sakellaridis, E1
Bernardi, M1
Gasbarrini, G1
Ohtomo, E1
Nakahiro, M1
Mochizuki, D1
Uchida, S1
Yoshida, H1
Houck, PR1
Reynolds, CF1
Bonavita, E1

Clinical Trials (4)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Kuopio Ischaemic Heart Disease Risk Factor Study (Nutrition Component)[NCT03221127]2,682 participants (Actual)Observational1984-03-01Active, not recruiting
Open Label Study for the Use of Tyrosine Kinase Inhibitors for Treatment of Cognitive Decline Due to Degenerative Dementias[NCT02921477]Phase 1150 participants (Anticipated)Interventional2016-09-30Enrolling by invitation
Focused Ultrasound Delivery of Exosomes for Treatment of Refractory Depression, Anxiety, and Neurodegenerative Dementias[NCT04202770]300 participants (Anticipated)Interventional2019-12-01Suspended (stopped due to Pending COVID-19 pandemic; pending status of product development)
An Open-label Exploratory Study With Memantine: Correlation Between Proton Magnetic Resonance Spectroscopy, Cerebrospinal Fluid Biomarkers, and Cognition in Patients With Mild to Moderate Alzheimer's Disease[NCT00551161]Phase 412 participants (Actual)Interventional2007-08-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

Changes in the Metabolite Ratios of N-acetylaspartate (NAA) to Creatine (Cr), Myo-inositol (mI) to Cr, Choline (Cho) to Cr, NAA to Cho, and NAA to mI, on Cholinesterase Monotherapy vs Combination of Memantine and Cholinesterase Inhibitor

Ratios of myo-inositol (mI), N-acetylaspartate (NAA), total creatine (Cr), and choline (Cho) by single voxel 1H MRS (proton magnetic resonance spectroscopy). Mean (± SD) metabolite levels (normalized to T2-corrected water signal intensity) and metabolite ratios for Alzheimer's disease subjects at baseline (t0), after 24 weeks of ongoing monotherapy with stable-dose cholinesterase inhibitor (t1), and after another 24 weeks of combination therapy with memantine in addition to stable-dose cholinesterase inhibitor (t2). The Wilcoxon signed-rank test was used to examine whether the change between t0 and t1 differed from the change between t1 and t2 [(t2 - t1) - (t1 - t0)]. (NCT00551161)
Timeframe: Baseline, 24 weeks, and 48 weeks

Interventionratio (normalized to T2-corrected water (Mean)
Change in NAA [(t2-t1) - (t1-t0)]Change in Cr [(t2-t1) - (t1-t0)]Change in Cho [(t2-t1) - (t1-t0)]Change in mI [(t2-t1) - (t1-t0)]Change in NAA/Cr [(t2-t1) - (t1-t0)]Change in Cho/Cr [(t2-t1) - (t1-t0)]Change in mI/Cr [(t2-t1) - (t1-t0)]Change in NAA/Cho [(t2-t1) - (t1-t0)]Change in NAA/mI [(t2-t1) - (t1-t0)]
Memantine-54-2916-0.090.020.04-0.26-0.35

Reviews

14 reviews available for choline and Dementia

ArticleYear
[Importance of choline in cognitive function].
    Nutricion hospitalaria, 2021, Jan-13, Volume: 37, Issue:Spec No2

    Topics: Adult; Aged; Aged, 80 and over; Choline; Cognition; Dementia; Diet; Female; Humans; Middle Aged; Neu

2021
Examining the relationship between nutrition and cerebral structural integrity in older adults without dementia.
    Nutrition research reviews, 2019, Volume: 32, Issue:1

    Topics: Aged; Aged, 80 and over; Aging; Brain; Choline; Cognition; Cognitive Dysfunction; Dementia; Diet; Di

2019
Proton MRS in mild cognitive impairment.
    Journal of magnetic resonance imaging : JMRI, 2013, Volume: 37, Issue:4

    Topics: Alzheimer Disease; Animals; Aspartic Acid; Biomarkers; Brain; Choline; Cognitive Dysfunction; Creati

2013
Cholinergic imaging in dementia spectrum disorders.
    European journal of nuclear medicine and molecular imaging, 2016, Volume: 43, Issue:7

    Topics: Choline; Dementia; Diagnostic Imaging; Humans; Synapses

2016
[Psychopharmacologic treatment of cognitive function disorders in aging persons: current possibilities].
    Tijdschrift voor gerontologie en geriatrie, 1984, Volume: 15, Issue:4

    Topics: Adrenocorticotropic Hormone; Aged; Alzheimer Disease; Anticonvulsants; Brain; Catecholamines; Cholin

1984
[Neurobiological and neurochemical aspects and therapeutic problems in aging and in dementia].
    La Clinica terapeutica, 1980, Oct-31, Volume: 95, Issue:2

    Topics: Age Factors; Aged; Aging; Brain Chemistry; Choline; Dementia; Humans; Nervous System; Nervous System

1980
Biological perspectives in chronic pain, depression, and organic mental disorders.
    The Psychiatric clinics of North America, 1981, Volume: 4, Issue:2

    Topics: Adrenocorticotropic Hormone; Adult; Aged; Animals; Antidepressive Agents; Antipsychotic Agents; Chol

1981
Neurotransmitter systems in aging and senile dementia.
    Progress in neuro-psychopharmacology, 1981, Volume: 5, Issue:5-6

    Topics: Acetylcholine; Aged; Aging; Animals; Brain; Choline; Clinical Trials as Topic; Dementia; Dopamine; g

1981
Clinical pharmacology of senile dementia.
    Progress in neuro-psychopharmacology, 1981, Volume: 5, Issue:5-6

    Topics: Aged; Aging; Anticoagulants; Arginine Vasopressin; Brain; Choline; Dementia; Dihydroergotoxine; Free

1981
An update on the neurochemistry of Alzheimer disease.
    Advances in neurology, 1983, Volume: 38

    Topics: Acetylcholinesterase; Alzheimer Disease; Arecoline; Brain; Choline; Choline O-Acetyltransferase; Cho

1983
[Aging of the nervous system--with special reference to dementia in the aged].
    Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics, 1983, Volume: 20, Issue:1

    Topics: Acetylcholine; Aged; Aging; Animals; Brain; Choline; Choline O-Acetyltransferase; Dementia; Humans;

1983
Alzheimer's disease: a challenging enigma.
    Archives of pathology & laboratory medicine, 1982, Volume: 106, Issue:4

    Topics: Aging; Animals; Brain; Cerebral Cortex; Choline; Choline O-Acetyltransferase; Cholinergic Fibers; De

1982
Biochemistry of Alzheimer's dementia.
    Journal of neurochemistry, 1982, Volume: 39, Issue:1

    Topics: Acetylcholine; Acetylcholinesterase; Alzheimer Disease; Animals; Brain; Cerebral Cortex; Choline; Ch

1982
[Recent drug therapy of senile dementia].
    No to shinkei = Brain and nerve, 1987, Volume: 39, Issue:1

    Topics: Adrenocorticotropic Hormone; Alzheimer Disease; Choline; Dementia; Dihydroergotoxine; Humans; Narcot

1987

Trials

13 trials available for choline and Dementia

ArticleYear
Associations of dietary choline intake with risk of incident dementia and with cognitive performance: the Kuopio Ischaemic Heart Disease Risk Factor Study.
    The American journal of clinical nutrition, 2019, 12-01, Volume: 110, Issue:6

    Topics: Adult; Apolipoprotein E4; Choline; Cognition; Dementia; Diet; Eggs; Finland; Follow-Up Studies; Huma

2019
Magnetic resonance spectroscopy performance for detection of dementia, Alzheimer's disease and mild cognitive impairment in a community-based survey.
    Dementia and geriatric cognitive disorders, 2008, Volume: 26, Issue:1

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Aspartic Acid; Brain; Choline; Cognition Disorders; Crea

2008
Neurotransmitter systems in aging and senile dementia.
    Progress in neuro-psychopharmacology, 1981, Volume: 5, Issue:5-6

    Topics: Acetylcholine; Aged; Aging; Animals; Brain; Choline; Clinical Trials as Topic; Dementia; Dopamine; g

1981
Double blind study of lecithin in patients with Alzheimer's disease.
    Canadian journal of psychiatry. Revue canadienne de psychiatrie, 1981, Volume: 26, Issue:6

    Topics: Aged; Alzheimer Disease; Choline; Clinical Trials as Topic; Dementia; Double-Blind Method; Female; H

1981
Fluctuations of free choline levels in plasma of Alzheimer patients receiving lecithin: preliminary observations.
    The British journal of psychiatry : the journal of mental science, 1982, Volume: 140

    Topics: Aged; Alzheimer Disease; Choline; Clinical Trials as Topic; Dementia; Double-Blind Method; Humans; M

1982
A dose-ranging study of lecithin in the treatment of primary degenerative dementia (Alzheimer disease).
    Journal of clinical psychopharmacology, 1982, Volume: 2, Issue:4

    Topics: Aged; Alzheimer Disease; Choline; Dementia; Double-Blind Method; Drug Evaluation; Erythrocytes; Fema

1982
Alzheimer disease: lack of effect of lecithin treatment for 3 months.
    Neurology, 1981, Volume: 31, Issue:12

    Topics: Aged; Alzheimer Disease; Choline; Dementia; Double-Blind Method; Humans; Middle Aged; Phosphatidylch

1981
Choline therapy in Alzheimer's disease.
    Lancet (London, England), 1978, Aug-05, Volume: 2, Issue:8084

    Topics: Aged; Alzheimer Disease; Choline; Clinical Trials as Topic; Dementia; Double-Blind Method; Drug Eval

1978
Influence of choline on amnesia in early Alzheimer's disease.
    Lancet (London, England), 1978, Oct-14, Volume: 2, Issue:8094

    Topics: Aged; Alzheimer Disease; Amnesia; Choline; Clinical Trials as Topic; Dementia; Humans; Memory; Middl

1978
Choline in Alzheimers disease.
    Lancet (London, England), 1978, Oct-28, Volume: 2, Issue:8096

    Topics: Alzheimer Disease; Choline; Clinical Trials as Topic; Dementia; Humans; Research Design

1978
Mental disorders: a new approach to treatment?
    Science (New York, N.Y.), 1979, Jan-05, Volume: 203, Issue:4375

    Topics: Acetylcholine; Brain; Choline; Clinical Trials as Topic; Dementia; Double-Blind Method; Dyskinesia,

1979
Choline in Alzheimer's disease.
    The New England journal of medicine, 1979, Aug-09, Volume: 301, Issue:6

    Topics: Aged; Alzheimer Disease; Choline; Clinical Trials as Topic; Dementia; Double-Blind Method; Female; H

1979
[Effect of CDP-choline on senile mental deterioration. Multicenter experience on 237 cases].
    Minerva medica, 1990, Volume: 81, Issue:6

    Topics: Activities of Daily Living; Aged; Aged, 80 and over; Choline; Cytidine Diphosphate Choline; Dementia

1990

Other Studies

62 other studies available for choline and Dementia

ArticleYear
Longitudinal Associations of Plasma TMAO and Related Metabolites with Cognitive Impairment and Dementia in Older Adults: The Cardiovascular Health Study.
    Journal of Alzheimer's disease : JAD, 2022, Volume: 89, Issue:4

    Topics: Animals; Betaine; Carnitine; Choline; Cognitive Dysfunction; Dementia; Medicare; Methylamines; Unite

2022
Choline and phosphatidylcholine may maintain cognitive performance by multiple mechanisms.
    The American journal of clinical nutrition, 2019, 12-01, Volume: 110, Issue:6

    Topics: Choline; Cognition; Dementia; Humans; Myocardial Ischemia; Phosphatidylcholines; Risk Factors

2019
Components of the choline oxidation pathway modify the association between the apolipoprotein ε4 gene variant and cognitive decline in patients with dementia.
    Brain research, 2020, 01-01, Volume: 1726

    Topics: Aged; Alzheimer Disease; Apolipoprotein E4; Choline; Cognitive Dysfunction; Dementia; Female; Humans

2020
Special issue on advances and controversies in B vitamins and choline.
    Clinical chemistry and laboratory medicine, 2013, Mar-01, Volume: 51, Issue:3

    Topics: Aging; Choline; Dementia; Dietary Supplements; Humans; Risk Factors; Vascular Diseases; Vitamin B Co

2013
Magnetic resonance spectroscopy as a predictor of conversion of mild cognitive impairment to dementia.
    Journal of the neurological sciences, 2013, Dec-15, Volume: 335, Issue:1-2

    Topics: Aged; Aged, 80 and over; Aspartic Acid; Brain; Choline; Cognitive Dysfunction; Creatine; Dementia; D

2013
Magnetic resonance spectroscopy as a predictor of conversion of mild cognitive impairment to dementia.
    Journal of the neurological sciences, 2013, Dec-15, Volume: 335, Issue:1-2

    Topics: Aged; Aged, 80 and over; Aspartic Acid; Brain; Choline; Cognitive Dysfunction; Creatine; Dementia; D

2013
Magnetic resonance spectroscopy as a predictor of conversion of mild cognitive impairment to dementia.
    Journal of the neurological sciences, 2013, Dec-15, Volume: 335, Issue:1-2

    Topics: Aged; Aged, 80 and over; Aspartic Acid; Brain; Choline; Cognitive Dysfunction; Creatine; Dementia; D

2013
Magnetic resonance spectroscopy as a predictor of conversion of mild cognitive impairment to dementia.
    Journal of the neurological sciences, 2013, Dec-15, Volume: 335, Issue:1-2

    Topics: Aged; Aged, 80 and over; Aspartic Acid; Brain; Choline; Cognitive Dysfunction; Creatine; Dementia; D

2013
Utility of SPM8 plus DARTEL (VSRAD) combined with magnetic resonance spectroscopy as adjunct techniques for screening and predicting dementia due to Alzheimer's disease in clinical practice.
    Journal of Alzheimer's disease : JAD, 2014, Volume: 41, Issue:4

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Aspartic Acid; Brain; Choline; De

2014
Metabolite ratios in the posterior cingulate cortex do not track cognitive decline in Parkinson's disease in a clinical setting.
    Parkinsonism & related disorders, 2016, Volume: 22

    Topics: Aged; Aged, 80 and over; Aspartic Acid; Bayes Theorem; Case-Control Studies; Choline; Cognitive Dysf

2016
Single voxel magnetic resonance spectroscopy at 3 Tesla in a memory disorders clinic: early right hippocampal NAA/Cr loss in mildly impaired subjects.
    Psychiatry research, 2008, Nov-30, Volume: 164, Issue:2

    Topics: Aged; Aspartic Acid; Choline; Creatine; Dementia; Female; Functional Laterality; Hippocampus; Humans

2008
Conversion to dementia in mild cognitive impairment is associated with decline of N-actylaspartate and creatine as revealed by magnetic resonance spectroscopy.
    Psychiatry research, 2009, Jul-15, Volume: 173, Issue:1

    Topics: Aged; Alzheimer Disease; Aspartic Acid; Brain; Choline; Cognition; Cognition Disorders; Creatine; De

2009
Cognitive impairment: assessment with brain magnetic resonance imaging and proton magnetic resonance spectroscopy.
    The Journal of clinical psychiatry, 2003, Volume: 64, Issue:3

    Topics: Aged; Alzheimer Disease; Aspartic Acid; Brain; Brain Chemistry; Choline; Cognition Disorders; Creati

2003
Posterior cingulate metabolic changes in frontotemporal lobar degeneration detected by magnetic resonance spectroscopy.
    Neuroradiology, 2004, Volume: 46, Issue:4

    Topics: Adult; Aged; Alzheimer Disease; Aspartic Acid; Case-Control Studies; Choline; Creatine; Dementia; Di

2004
1H MR spectroscopy in common dementias.
    Neurology, 2004, Oct-26, Volume: 63, Issue:8

    Topics: Acetylcholine; Aged; Aged, 80 and over; Alzheimer Disease; Aspartic Acid; Brain; Brain Chemistry; Ch

2004
In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease.
    Progress in neuro-psychopharmacology & biological psychiatry, 2004, Volume: 28, Issue:8

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Analysis of Variance; Aspartic Acid; Brain Mapping; Case

2004
Cortical NAA deficits in HIV infection without dementia: influence of alcoholism comorbidity.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2005, Volume: 30, Issue:7

    Topics: Adult; Alcoholism; Aspartic Acid; Brain Mapping; Case-Control Studies; Cerebral Cortex; Choline; Com

2005
Conversion of MCI to dementia: Role of proton magnetic resonance spectroscopy.
    Neurobiology of aging, 2006, Volume: 27, Issue:7

    Topics: Aged; Amnesia; Aspartic Acid; Cerebral Cortex; Choline; Cognition Disorders; Creatine; Dementia; Dis

2006
Naming is associated with left temporal pole metabolite levels in neurodegenerative diseases.
    Dementia and geriatric cognitive disorders, 2008, Volume: 25, Issue:3

    Topics: Aged; Amnesia; Anomia; Aspartic Acid; Choline; Cognition Disorders; Creatine; Dementia; Female; Huma

2008
Proton magnetic resonance spectroscopy detects a relative decrease of N-acetylaspartate in the hippocampus of patients with dementia with Lewy bodies.
    Journal of neuroimaging : official journal of the American Society of Neuroimaging, 2008, Volume: 18, Issue:2

    Topics: Aged; Aspartic Acid; Chi-Square Distribution; Choline; Creatine; Dementia; Female; Hippocampus; Huma

2008
Drugs for senile dementia.
    Drugs, 1980, Volume: 20, Issue:1

    Topics: Aged; Antidepressive Agents, Tricyclic; Central Nervous System Stimulants; Choline; Dementia; Dihydr

1980
Cholinergic precursors in Alzheimer's disease.
    Lancet (London, England), 1982, Nov-06, Volume: 2, Issue:8306

    Topics: Alzheimer Disease; Choline; Dementia; Humans; Pilocarpine; Receptors, Muscarinic

1982
Choline precursors and Alzheimer's disease.
    Lancet (London, England), 1982, Dec-25, Volume: 2, Issue:8313

    Topics: Alzheimer Disease; Brain; Choline; Dementia; Humans

1982
Dementia in the aged.
    The Psychiatric clinics of North America, 1982, Volume: 5, Issue:1

    Topics: Aged; Cerebral Infarction; Choline; Creutzfeldt-Jakob Syndrome; Dementia; Depressive Disorder; Diagn

1982
Alzheimer's disease and Down's syndrome.
    Annals of the New York Academy of Sciences, 1982, Volume: 396

    Topics: Acetylcholinesterase; Adult; Aged; Aging; Alzheimer Disease; Animals; Axons; Brain; Choline; Choline

1982
Elevation of RBC glycine and choline levels in geriatric patients treated with lithium.
    The American journal of psychiatry, 1983, Volume: 140, Issue:7

    Topics: Aged; Alzheimer Disease; Choline; Cognition Disorders; Dementia; Erythrocytes; Female; Glycine; Huma

1983
Choline production from choline-containing phospholipids: a hypothetical role in Alzheimer's disease and aging.
    Progress in neuro-psychopharmacology & biological psychiatry, 1984, Volume: 8, Issue:4-6

    Topics: Acetylcholine; Aging; Alzheimer Disease; Animals; Brain; Cell Membrane; Choline; Cholinergic Fibers;

1984
Relationship between nutrition and dementia in the elderly.
    Psychiatric medicine, 1983, Volume: 1, Issue:4

    Topics: Acetylcholine; Aged; Aged, 80 and over; Aging; Aluminum; Choline; Cognition; Dementia; Folic Acid; H

1983
[Dementia syndromes and epilepsy].
    Minerva medica, 1984, Feb-18, Volume: 75, Issue:6

    Topics: Adult; Aged; Alzheimer Disease; Choline; Dementia; Electroencephalography; Epilepsy; Female; Humans;

1984
Presynaptic cholinergic dysfunction in patients with dementia.
    Journal of neurochemistry, 1983, Volume: 40, Issue:2

    Topics: Acetylcholine; Adult; Aged; Alzheimer Disease; Carbon Radioisotopes; Cerebral Cortex; Choline; Choli

1983
The responsiveness of human eccrine sweat glands to choline and carbachol. Application to the study of peripheral cholinergic functioning in Alzheimer-type dementia.
    European journal of clinical pharmacology, 1983, Volume: 24, Issue:1

    Topics: Adult; Aged; Aging; Alzheimer Disease; Carbachol; Choline; Dementia; Dose-Response Relationship, Dru

1983
[Citicoline activity in senile mental decay].
    Minerva medica, 1983, Apr-07, Volume: 74, Issue:14-15

    Topics: Aged; Choline; Cytidine Diphosphate Choline; Dementia; Drug Evaluation; Female; Humans; Injections,

1983
Failure of single-dose lecithin to alter aspects of central cholinergic activity in Alzheimer's disease.
    The Journal of clinical psychiatry, 1983, Volume: 44, Issue:8

    Topics: Aged; Alzheimer Disease; Blood Pressure; Choline; Dementia; Erythrocytes; Female; Humans; Hydrocorti

1983
Lecithin does not affect EEG spectral analysis or P300 in Alzheimer disease.
    Neurology, 1982, Volume: 32, Issue:11

    Topics: Aged; Alzheimer Disease; Choline; Dementia; Electroencephalography; Evoked Potentials; Female; Human

1982
Red-cell/plasma choline ratio in dementia.
    The New England journal of medicine, 1982, Aug-19, Volume: 307, Issue:8

    Topics: Choline; Dementia; Erythrocytes; Humans; Plasma

1982
Cerebrospinal fluid acetylcholine, choline, and senile dementia of the Alzheimer's type.
    Psychopharmacology bulletin, 1982, Volume: 18, Issue:4

    Topics: Acetylcholine; Aged; Alzheimer Disease; Choline; Dementia; Female; Humans; Male; Middle Aged

1982
Clinical response to choline plus piracetam in senile dementia: relation to red-cell choline levels.
    The New England journal of medicine, 1981, 06-11, Volume: 304, Issue:24

    Topics: Choline; Dementia; Drug Therapy, Combination; Erythrocytes; Humans; Piracetam; Pyrrolidinones

1981
Choline uptake in patients with Alzheimer pre-senile dementia.
    Psychological medicine, 1981, Volume: 11, Issue:3

    Topics: Adolescent; Adult; Aged; Alzheimer Disease; Choline; Dementia; Erythrocytes; Female; Humans; Male; M

1981
Preventing senile dementia: hope for the future.
    Geriatrics, 1981, Volume: 36, Issue:9

    Topics: Aged; Choline; Dementia; Dihydroergotoxine; Female; Humans; Male; Memory; Middle Aged; Piracetam

1981
Choline chloride fails to improve cognition of Alzheimer's disease.
    Neurobiology of aging, 1981,Fall, Volume: 2, Issue:3

    Topics: Aged; Alzheimer Disease; Choline; Cognition; Dementia; Diarrhea; Dose-Response Relationship, Drug; D

1981
Choline chloride in Alzheimer disease.
    Annals of neurology, 1981, Volume: 10, Issue:6

    Topics: Alzheimer Disease; Choline; Dementia; Humans

1981
Choline, acetylcholine and dementia.
    Psychological medicine, 1980, Volume: 10, Issue:1

    Topics: Acetylcholine; Choline; Choline O-Acetyltransferase; Cholinesterase Inhibitors; Dementia; Humans

1980
Acetylcholine and choline levels in post-mortem human brain tissue: preliminary observations in Alzheimer's disease.
    Life sciences, 1980, May-19, Volume: 26, Issue:20

    Topics: Acetylcholine; Aged; Alzheimer Disease; Animals; Brain; Caudate Nucleus; Cerebral Cortex; Choline; D

1980
Neurochemical approaches to the treatment of senile dementia.
    Proceedings of the annual meeting of the American Psychopathological Association, 1980, Volume: 69

    Topics: Acetylcholine; Aged; Alzheimer Disease; Animals; Choline; Choline O-Acetyltransferase; Dementia; Dys

1980
Choline bitartrate treatment of Alzheimer-type dementias.
    Communications in psychopharmacology, 1980, Volume: 4, Issue:2

    Topics: Aged; Alzheimer Disease; Behavior; Choline; Cognition; Dementia; Double-Blind Method; Female; Humans

1980
Human memory and the effects of physostigmine and choline chloride [proceedings].
    Psychopharmacology bulletin, 1980, Volume: 16, Issue:4

    Topics: Adolescent; Adult; Aged; Choline; Dementia; Double-Blind Method; Humans; Memory; Middle Aged; Physos

1980
H-1 MR spectroscopic imaging of white matter signal hyperintensities: Alzheimer disease and ischemic vascular dementia.
    Radiology, 1995, Volume: 197, Issue:2

    Topics: Aged; Alzheimer Disease; Aspartic Acid; Brain; Brain Diseases; Brain Ischemia; Case-Control Studies;

1995
Role of increased cerebral myo-inositol in the dementia of Down syndrome.
    Magnetic resonance in medicine, 1995, Volume: 33, Issue:6

    Topics: Adolescent; Adult; Alzheimer Disease; Aspartic Acid; Brain; Child; Child, Preschool; Choline; Creati

1995
Decreased brain choline uptake in older adults. An in vivo proton magnetic resonance spectroscopy study.
    JAMA, 1995, Sep-20, Volume: 274, Issue:11

    Topics: Adult; Age Factors; Aged; Aged, 80 and over; Aging; Analysis of Variance; Blood-Brain Barrier; Brain

1995
Administration of phosphatidylcholine increases brain acetylcholine concentration and improves memory in mice with dementia.
    The Journal of nutrition, 1995, Volume: 125, Issue:6

    Topics: Acetylcholine; Animals; Brain; Brain Chemistry; Cerebral Cortex; Choline; Dementia; Female; Hippocam

1995
Proton MR spectroscopy of the brain in 14 patients with Parkinson disease.
    AJNR. American journal of neuroradiology, 1995, Volume: 16, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Aspartic Acid; Brain; Choline; Creatine; Dementia; Energy Metabolism

1995
[Experimental techniques for developing new drugs acting on dementia (4)--Aged rats].
    Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology, 1994, Volume: 14, Issue:4

    Topics: Acetylcholinesterase; Aging; Animals; Choline; Choline O-Acetyltransferase; Dementia; Female; Male;

1994
Alterations of selected enzymes of phospholipid metabolism in Alzheimer's disease brain tissue as compared to non-Alzheimer's demented controls.
    Neurochemical research, 1993, Volume: 18, Issue:3

    Topics: Aged; Alzheimer Disease; Brain; Choline; Choline Kinase; Dementia; Humans; Phospholipids; Phosphoric

1993
Brain metabolite concentration and dementia severity in Alzheimer's disease: a (1)H MRS study.
    Neurology, 2001, Aug-28, Volume: 57, Issue:4

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Analysis of Variance; Aspartic Acid; Brain; Choline; Cre

2001
Clinical effects of choline in Alzheimer senile dementia.
    Lancet (London, England), 1977, Oct-01, Volume: 2, Issue:8040

    Topics: Administration, Oral; Aged; Alzheimer Disease; Choline; Dementia; Drug Evaluation; Female; Humans; M

1977
Choline in Alzheimer's disease.
    Lancet (London, England), 1977, Oct-15, Volume: 2, Issue:8042

    Topics: Aged; Alzheimer Disease; Cerebral Cortex; Choline; Choline O-Acetyltransferase; Dementia; gamma-Amin

1977
Clinical effects of choline in Alzheimer's disease.
    Lancet (London, England), 1978, Mar-04, Volume: 1, Issue:8062

    Topics: Aged; Alzheimer Disease; Choline; Dementia; Female; Humans; Male

1978
Possible biochemical basis of memory disorder in Alzheimer disease.
    Annals of neurology, 1978, Volume: 3, Issue:6

    Topics: Acetylcholine; Acetylcholinesterase; Alzheimer Disease; Animals; Choline; Choline O-Acetyltransferas

1978
Will drugs help patients with Alzheimer's disease?
    Age and ageing, 1979, Volume: 8, Issue:2

    Topics: Alzheimer Disease; Choline; Choline O-Acetyltransferase; Dementia; Humans

1979
[Influence of choline on amnesia in Alzheimer's disease (author's transl)].
    Revue neurologique, 1979, Volume: 135, Issue:8-9

    Topics: Aged; Alzheimer Disease; Amnesia; Choline; Dementia; Female; Humans; Learning; Male; Mental Recall;

1979
The arteriovenous difference of choline across the brain of man.
    Brain research, 1975, Dec-05, Volume: 99, Issue:2

    Topics: Adult; Aged; Brain; Choline; Dementia; Female; Humans; Male; Middle Aged

1975
Erythrocyte choline concentrations in psychiatric disorders.
    Biological psychiatry, 1991, Feb-15, Volume: 29, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Antidepressive Agents; Bipolar Disorder; Choline; Dementia; Depressi

1991
Effect of the 'antidementia drug' pantoyl-GABA on high affinity transport of choline and on the contents of choline and acetylcholine in rat brain.
    British journal of pharmacology, 1988, Volume: 95, Issue:4

    Topics: Acetylcholine; Animals; Biological Transport, Active; Brain; Choline; Dementia; gamma-Aminobutyric A

1988
Red blood cell/plasma choline ratio in elderly depressed and demented patients.
    Psychiatry research, 1988, Volume: 24, Issue:1

    Topics: Aged; Alzheimer Disease; Choline; Dementia; Depressive Disorder; Electroencephalography; Erythrocyte

1988
[Neuropsychological study of the senile brain during and after single and combined treatment with deanol and citicoline].
    La Clinica terapeutica, 1986, Jun-15, Volume: 117, Issue:5

    Topics: Aged; Choline; Cytidine Diphosphate Choline; Deanol; Dementia; Double-Blind Method; Drug Evaluation;

1986